<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id>
      <journal-title-group>
        <journal-title>Revista Brasileira de Terapia Intensiva</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0103-507X</issn>
      <issn pub-type="epub">1982-4335</issn>
      <publisher>
        <publisher-name>Associa&#xE7;&#xE3;o Brasileira de Medicina intensiva</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26340160</article-id>
      <article-id pub-id-type="pmc">4489788</article-id>
      <article-id pub-id-type="doi">10.5935/0103-507X.20150031</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Aortic and tricuspid endocarditis in hemodialysis patient with systemic
and pulmonary embolism</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Endocardite a&#xF3;rtica e tric&#xFA;spide em pacientes de
hemodi&#xE1;lise com embolia sist&#xEA;mica e pulmonar</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rosa</surname>
            <given-names>Silvia Aguiar</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Germano</surname>
            <given-names>Nuno</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Ana</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bento</surname>
            <given-names>Luis</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Department of Cardiology, Centro Hospitalar de Lisboa
Central, EPE - Lisboa, Portugal.</aff>
      <aff id="aff02"><label>2</label>Critical Care Medicine, Centro Hospitalar de Lisboa
Central, EPE - Lisboa, Portugal.</aff>
      <author-notes>
        <corresp id="c01"><bold>Corresponding author:</bold> Silvia Aguiar Rosa, Hospital de
Santa Marta, Centro Hospitalar de Lisboa Central, EPE, Rua de Santa Marta, 1169-024 -
Lisboa, Portugal. E-mail: <email>silviaguiarosa@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>27</volume>
      <issue>2</issue>
      <fpage>185</fpage>
      <lpage>189</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution NonCommercial License which permits unrestricted noncommercial
use, distribution, and reproduction in any medium provided the original work is
properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>This is a case report of a 43-year-old Caucasian male with end-stage renal disease
being treated with hemodialysis and infective endocarditis in the aortic and
tricuspid valves. The clinical presentation was dominated by neurologic impairment
with cerebral embolism and hemorrhagic components. A thoracoabdominal computerized
tomography scan revealed septic pulmonary embolus. The patient underwent empirical
antibiotherapy with ceftriaxone, gentamicin and vancomycin, and the therapy was
changed to flucloxacilin and gentamicin after the isolation of <italic>S.
aureus</italic> in blood cultures. The multidisciplinary team determined that the
patient should undergo valve replacement after the stabilization of the intracranial
hemorrhage; however, on the 8<sup>th</sup> day of hospitalization, the patient
entered cardiac arrest due to a massive septic pulmonary embolism and died. Despite
the risk of aggravation of the hemorrhagic cerebral lesion, early surgical
intervention should be considered in high-risk patients.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Este artigo relata o caso de um homem caucasiano de 43 anos de idade com nefropatia
terminal em tratamento com hemodi&#xE1;lise e apresentando endocardite infecciosa
das v&#xE1;lvulas a&#xF3;rtica e tric&#xFA;spide. O quadro cl&#xED;nico foi
dominado pelo comprometimento neurol&#xF3;gico, devido &#xE0; embolia cerebral e
a componentes hemorr&#xE1;gicos. Uma tomografia computadorizada
t&#xF3;raco-abdominal revelou um &#xEA;mbolo s&#xE9;ptico pulmonar. O paciente
foi submetido &#xE0; antibioticoterapia emp&#xED;rica utilizando ceftriaxona,
gentamicina e vancomicina, sendo o tratamento modificado para flucloxacilina e
gentamicina ap&#xF3;s o isolamento de <italic>S. aureus</italic> nas hemoculturas.
A equipe multidisciplinar determinou que o paciente deveria ser submetido &#xE0;
substitui&#xE7;&#xE3;o de v&#xE1;lvulas ap&#xF3;s estabiliza&#xE7;&#xE3;o da hemorragia
intracraniana; contudo, no oitavo dia ap&#xF3;s a hospitaliza&#xE7;&#xE3;o, o paciente
entrou em parada card&#xED;aca causada por embolia s&#xE9;ptica pulmonar maci&#xE7;a,
vindo a falecer. Apesar do risco de agravamento da les&#xE3;o hemorr&#xE1;gica
cerebral, em pacientes de alto risco deveria ser considerado realizar precocemente
uma interven&#xE7;&#xE3;o cir&#xFA;rgica.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Endocarditis/etiology</kwd>
        <kwd>Renal dialysis</kwd>
        <kwd>Embolism</kwd>
        <kwd>Aortic valve</kwd>
        <kwd>Tricuspid valve</kwd>
        <kwd>Tomography, x-ray computed</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Infective endocarditis (IE) is a severe infection that primarily involves the
endocardium of the cardiac valve leaflets. IE is more frequent in hemodialysis patients
than it is in the general population, and <italic>S. aureus</italic> is the main
infective agent.</p>
      <p>Neurologic involvement is a frequent complication of IE. Despite the formal surgical
indications for cerebral embolism, the timing of surgical intervention is controversial,
particularly in cases with a coexistent intracranial hemorrhage.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup></p>
      <p>Here, the authors describe a case with an unusual location of IE in multiple valves in a
patient on hemodialysis with severe systemic and pulmonary embolic presentation. Despite
the administration of the appropriate antibiotic therapy, embolic events continued to
occur with the deterioration of the patient&#x2019;s clinical status. The management of this
patient was a challenge due to comorbidities and concomitant intracranial hemorrhage
that precluded early surgical intervention.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Here, the authors report a case of a 43-year-old Caucasian man with a medical history of
end-stage renal disease due to hypertensive nephropathy and a 4-year history of
hemodialysis. Prior to the initiation of hemodialysis, the patient underwent renal
transplantation and rejected the allograft after 5 years due to voluntary
discontinuation of immunosuppressive therapy. He was admitted to the hospital with
fever, malaise, altered mental state and chest pain. Physical examination revealed
cognitive impairment with incoherent speech, left arm weakness, exacerbated
osteotendinous reflexes, the presence of the Babinski reflex on the right side and three
episodes of complex partial seizures. He was medicated with valproic acid and fenitoin
for seizure control.</p>
      <p>Relevant laboratory findings included creatinine 13.17mg/dL, urea 203 mg/dl, potassium
7.4mEq/L, leucocytosis 20,000/dL, C-reactive protein 411.5mg/L, troponin I 2.7ng/mL and
myoglobin 317IU/L.</p>
      <p>An electrocardiogram showed ST segment elevation in DII, DIII, aVF, V2 and V3 with
upward concavity and depression of the PR segment in DII, V2 and V3.</p>
      <p>Transthoracic echocardiography revealed normal left ventricular dimensions and systolic
function with no left atrial enlargement; furthermore, the right cavities were not
dilated, and the right ventricular systolic function was preserved. A mild pericardial
effusion with no evidence of vegetation in the valve leaflets was observed.</p>
      <p>A computerized tomography scan of the brain revealed a right frontal
cortical-subcortical lesion with ischemic and hemorrhagic components (<xref ref-type="fig" rid="f01">Figure 1</xref>). Magnetic resonance imaging confirmed
multiple hemorrhagic lesions in both cerebral hemispheres (<xref ref-type="fig" rid="f02">Figure 2</xref>). A thoracoabdominal computerized tomography scan revealed
septic pulmonary embolus and a splenic infarction. The diagnostic hypothesis was IE, and
the patient underwent transesophageal echocardiography, which identified vegetations in
the aortic and tricuspid valves of 9.13mm and 11.73mm in size, respectively (<xref ref-type="fig" rid="f03">Figures 3</xref> and <xref ref-type="fig" rid="f04">4</xref>), with mild aortic regurgitation and moderate tricuspid regurgitation.
Empirical treatment with ceftriaxone, gentamicin and vancomycin was initiated. Blood
cultures were positive for methicillin-sensitive <italic>S. aureus</italic>, and the
empirical treatment was changed to flucloxacilin and gentamicin. Cerebral spinal fluid
was unremarkable, and its culture was sterile. The pericardial effusion became bulkier
and generated late diastolic inward motion of the right ventricular free wall and the
right atrium, which necessitated pericardiocentesis.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Cortico-subcortical right frontal hypodensity (arrow) with mild hyperdensity
(arrow head) - ischemic area with intracerebral hemorrhagic component observed on
brain computerized tomography.</p>
        </caption>
        <graphic xlink:href="rbti-27-02-0185-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Multifocal lesions distributed in both cerebral hemispheres (arrow heads) and a
right frontal hemorrhagic component (arrow) observed on T2 brain magnetic
resonance imaging.</p>
        </caption>
        <graphic xlink:href="rbti-27-02-0185-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Transesophageal echocardiography showing vegetation in aortic valve 9.13mm in
size.</p>
        </caption>
        <graphic xlink:href="rbti-27-02-0185-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Transesophageal echocardiography demonstrating vegetation in tricuspid
valve11.73mm in size.</p>
        </caption>
        <graphic xlink:href="rbti-27-02-0185-g04"/>
      </fig>
      <p>Despite the administration of effective antibiotic therapy, cerebrovascular embolic
events persisted with neurologic deterioration. The multidisciplinary team decided that
the patient should undergo valve replacement after the stabilization of the intracranial
hemorrhage. However, on the 8<sup>th</sup> day after hospitalization, the patient
entered cardiac arrest and was recovered with advanced life support. Transthoracic
echocardiography after resuscitation demonstrated an enlargement of the right cavities
and right ventricular hypocinesia, and the presumed diagnosis was a massive septic
pulmonary embolism. The patient re-entered cardiac arrest, and although fibrinolysis was
performed and advanced life support was maintained for 40 minutes, the patient died.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In hemodialysis patients, IE has an incidence of 308/100,000 patients/year, and this is
50-180-fold higher than the incidence in the general population.<sup>(<xref rid="r02" ref-type="bibr">2</xref>)</sup> The risk factors in this group include
recurrent bacteremia during hemodialysis, uremia, immune injury and premature
degenerative heart valve disease due to abnormalities in calcium-phosphorus homeostasis
and chronic inflammation.<sup>(<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>)</sup>
<italic>S. aureus</italic> is the main infective agent in IE and causes 50 to 80% of IE
cases (50% of which are methicillin resistant).<sup>(<xref rid="r03" ref-type="bibr">3</xref>)</sup> This reflects the rate of infection of hemodialysis intravascular
devices and the fact that 50% of all hemodialysis patients are carriers of <italic>S.
aureus</italic>. Despite the relationship between hemodialysis devices and IE in
these patients, infection of right-sided valves is rare. The mitral valve is the most
frequently infected valve (50%), followed by the aortic valve (40%). Tricuspid IE only
constitutes approximately 10% of the cases. Multiple valves, usually the mitral and
aortic valves, are involved in 20% of such cases.<sup>(<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>)</sup> The degenerative disease
of left-sided heart valves might explain the difference in incidence.<sup>(<xref rid="r03" ref-type="bibr">3</xref>)</sup></p>
      <p>Following cardiovascular disease, IE is the second most common cause of death in
hemodialysis patients. The mortality of IE in these patients is 30 - 60%, which is
considerably higher than that in the general population, probably due to the high
prevalence of <italic>S. aureus</italic> and multiple comorbid conditions in
hemodialysis patients. Age, diabetes, septic embolism involving cerebrovascular events,
mitral valve involvement, great vegetation and <italic>S. aureus</italic> infection are
factors that result in a poor prognosis in IE patients.<sup>(<xref rid="r03" ref-type="bibr">3</xref>)</sup></p>
      <p>The indications for valve replacement in the general population are defined in the
European Society of Cardiology guidelines. However, there is no consensus regarding
whether these guidelines are applicable to hemodialysis patients, and data regarding
surgical decisions in these patients are lacking. According to the European Society of
Cardiology guidelines for the management of IE, embolic events are an indication for
surgical intervention. The brain and the spleen and lungs are the most frequent sites of
embolism in left and right-sided IE, respectively. Embolism occurs in 22% to 50% of
patients with IE. The predictors of embolism are vegetation size greater than 10mm,
mitral location and infection with <italic>S. aureus.</italic><sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref>)</sup></p>
      <p>The current guidelines indicate that after a transient ischemic attack or stroke,
surgery should not be delayed, but following an intracranial hemorrhage, the guidelines
state that surgery must be delayed for one month.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup> However, Yoshioka et al. suggested that the risk of neurological
deterioration after surgery is relatively low, even in IE patients who underwent valve
replacement less than 2 weeks after intracranial hemorrhage.<sup>(<xref rid="r06" ref-type="bibr">6</xref>)</sup> In patients who are on hemodialysis, perioperative
mortality is high, probably because the patients who are selected for surgery have more
severe disease and complications. It has been suggested that patients with high
mortality risk should undergo earlier surgery than the general population
should.<sup>(<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r05" ref-type="bibr">5</xref>)</sup> In a recent study, patients who underwent surgery had a
higher survival rate than those who did not.<sup>(<xref rid="r02" ref-type="bibr">2</xref>)</sup></p>
      <p>The size and mobility of vegetations are the most important factors associated with
embolism; therefore, even in the absence of an embolic event, surgical treatment should
be considered in cases with vegetation with a length of 15mm or 10mm and other
predictors of a complicated course.<sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r07" ref-type="bibr">7</xref>)</sup></p>
      <p>In addition to embolism, the other two main indications for surgery in the context of IE
are heart failure and uncontrolled infection.</p>
      <p>Heart failure in IE is caused by valve destruction and results in severe regurgitation,
intracardiac fistulae or valve obstruction. Heart failure is more frequent in aortic IE
than it is in mitral IE. The timing of surgery depends on the patient&#x2019;s clinical
features. In cases of persistent pulmonary edema or cardiogenic shock, immediate
intervention should be performed. If severe valve regurgitation is well tolerated, a
conservative approach with antibiotics is recommended, and surgery is indicated after
resolution of IE.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup></p>
      <p>A perivalvular abscess, pseudoaneurysm and fistulae are frequent complications of
uncontrolled infection. The more common location of these complications is the aortic
valve, particularly in the mitral-aortic intervalvular fibrosa. Unexplained fever or new
atrioventricular block should raise the suspicion of perivalvular infection extension,
and this should be confirmed by transesophageal echocardiography. In these cases,
surgery is indicated as soon as possible. An intervention is also recommended in case of
persistent fever or positive blood cultures and extracardiac abscesses, or if the IE is
caused by a multiresistant organisms.<sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r08" ref-type="bibr">8</xref>)</sup></p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>This clinical report describes a case with an unusual location of infective endocarditis
in multiple valves in a patient on hemodialysis with severe embolic presentation.
Although there is no consensus regarding the optimal timing for surgery, it seems that
early intervention could prevent disease aggravation, despite the risk of hemorrhagic
lesion exacerbation.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of interest:</bold> None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Responsible editor:</bold> Thiago Costa Lisboa</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Habib</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hoen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tornos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Thuny</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Prendergast</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vilacosta</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Moreillon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>de Jesus Antunes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thilen</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lekakis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lengyel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Naber</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Nihoyannopoulos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moritz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zamorano</surname>
              <given-names>JL</given-names>
            </name>
            <collab>ESC Committee for Practice Guidelines</collab>
          </person-group>
          <article-title>Guidelines on the prevention, diagnosis, and treatment of infective
endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and
Treatment of Infective Endocarditis of the European Society of Cardiology (ESC).
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases
(ESCMID) and the International Society of Chemotherapy (ISC) for Infection and
Cancer</article-title>
          <source>Eur Heart J</source>
          <year>2009</year>
          <volume>30</volume>
          <issue>19</issue>
          <fpage>2369</fpage>
          <lpage>2413</lpage>
          <pub-id pub-id-type="pmid">19713420</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamalakannan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pai</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Gardin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Saravolatz</surname>
              <given-names>LD</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology and clinical outcomes of infective endocarditis in
hemodialysis patients</article-title>
          <source>Ann Thorac Surg</source>
          <year>2007</year>
          <volume>83</volume>
          <issue>6</issue>
          <fpage>2081</fpage>
          <lpage>2086</lpage>
          <pub-id pub-id-type="pmid">17532401</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nucifora</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Badano</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Viale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gianfagna</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Allocca</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Montanaro</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Infective endocarditis in chronic haemodialysis patients: an
increasing clinical challenge</article-title>
          <source>Eur Heart J</source>
          <year>2007</year>
          <volume>28</volume>
          <issue>19</issue>
          <fpage>2307</fpage>
          <lpage>2312</lpage>
          <pub-id pub-id-type="pmid">17656347</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keynan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Singal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Arora</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Rubinstein</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Infective endocarditis in the intensive care unit</article-title>
          <source>Crit Care Clin</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>4</issue>
          <fpage>923</fpage>
          <lpage>951</lpage>
          <pub-id pub-id-type="pmid">24094385</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leither</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Shroff</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Long-term survival of dialysis patients with bacterial endocarditis
undergoing valvular replacement surgery in the United States</article-title>
          <source>Circulation</source>
          <year>2013</year>
          <volume>128</volume>
          <issue>4</issue>
          <fpage>344</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="pmid">23785002</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshioka</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Toda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamauchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miyagawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshikawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sawa</surname>
              <given-names>Y</given-names>
            </name>
            <collab>OSCAR study group</collab>
          </person-group>
          <article-title>Valve surgery in active endocarditis patients complicated by
intracranial haemorrhage: the influence of the timing of surgery on neurological
outcomes</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>2014</year>
          <volume>45</volume>
          <issue>6</issue>
          <fpage>1082</fpage>
          <lpage>1088</lpage>
          <pub-id pub-id-type="pmid">24412832</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thuny</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Di Salvo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Belliard</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Avierinos</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Pergola</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk of embolism and death in infective endocarditis: prognostic value
of echocardiography: a prospective multicenter study</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>112</volume>
          <issue>1</issue>
          <fpage>69</fpage>
          <lpage>75</lpage>
          <comment>Erratum in: Circulation. 2005;112(9):e125. Disalvo, Giovanni
[corrected to Di Salvo, Giovanni]; Calabro, Raffaello
[corrected to Calabr&#xF3;, Raffaele]</comment>
          <pub-id pub-id-type="pmid">15983252</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graupner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vilacosta</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>SanRom&#xE1;n</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ronderos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sarri&#xE1;</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periannular extension of infective endocarditis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2002</year>
          <volume>39</volume>
          <issue>7</issue>
          <fpage>1204</fpage>
          <lpage>1211</lpage>
          <pub-id pub-id-type="pmid">11923047</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
